Plakophilin 2 (PKP2) is the most frequently mutated gene in ARVC, and although altered RNA splicing has been implicated, there are no models to study its effect and therapeutics. This evidence concerns the gene PKP2 and arrhythmogenic right ventricular cardiomyopathy.